Vanguard Global Advisers’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
4,961
﹤0.01% 3405
2026
Q1
$19.7K Buy
+4,961
New +$22K ﹤0.01% 3314

Other funds holding SRTS

Vanguard Global Advisers's SRTS Position: Q2 2026 in Review

Vanguard Global Advisers held its Sensus Healthcare (SRTS) position steady in Q2 2026 at 4,961 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

Vanguard Global Advisers first reported a position in SRTS in Q1 2026 and has held it in 2 quarters since. The position peaked at $19.7K in Q1 2026. 37 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Vanguard Global Advisers held 4,961 shares of Sensus Healthcare worth $15K as of Q2 2026.
  • Vanguard Global Advisers left its Sensus Healthcare share count unchanged in Q2 2026.
  • Sensus Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3405 holding.
  • Vanguard Global Advisers first reported a position in Sensus Healthcare in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Sensus Healthcare position peaked at $19.7K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.